Amgen Inc (AMGN.O)
27 Sep 2016
* Amgen stock down about 1.2 pct (Adds comments from conference call, analysts, details)
WASHINGTON The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar version of AbbVie's top-selling arthritis drug, Humira.
WASHINGTON, Sept 23 The U.S. Food and Drug Administration on Friday approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
Amgen Inc said on Tuesday its potent new cholesterol fighter, Repatha, met the primary and secondary goals of a study designed to show it can decrease plaque buildup in heart arteries of patients already taking widely used statin drugs, such as Lipitor.
BRIEF-Amgen announces positive top line results from Phase 3 GLAGOV imaging study of Repatha(evolocumab)
* Intravascular ultrasound study meets primary and secondary endpoints
A federal judge in Florida has ruled that Apotex Inc would not infringe an Amgen Inc patent by making copycat versions of Amgen's white-blood-cell-boosting drugs Neulasta and Neupogen.
* Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational bite immuno-oncology drug for multiple myeloma
* Amgen and Servier extend omecamtiv mecarbil collaboration in chronic heart failure
* Cytokinetics and Amgen to advance Omecamtiv Mecarbil to phase 3 clinical development
* Swiss drugmaker fighting Amgen on patents, regulatory hurdles
|Takeda Pharmaceutical Co Ltd (4502.T)||¥4,815||-81.00|
|Johnson & Johnson (JNJ.N)||$119.22||+1.44|
|Novartis AG (NOVN.S)||CHF78.10||--|
|Merck & Co., Inc. (MRK.N)||$62.57||+0.42|
|Roche Holding Ltd. (ROG.S)||CHF243.50||--|
|Roche Holding Ltd. (RO.S)||CHF244.10||--|
|Teva Pharmaceutical Industries Limited (TEVA.TA)||18,810.00₪||-330.00|
|AbbVie Inc (ABBV.N)||$64.57||+0.50|
|Eli Lilly and Co (LLY.N)||$80.88||+1.36|
|Bristol-Myers Squibb Co (BMY.N)||$55.74||+0.26|
Earnings vs. Estimates
Analyst Research Reports
Provider : Thomson Reuters Stock Report
Trading Report for (AMGN). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : Wright Reports
Provider : ValuEngine, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.